Literature DB >> 3970477

Intravenous amrinone: an advance or a wrong step?

J A Franciosa.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3970477     DOI： 10.7326/0003-4819-102-3-399

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  4 in total

1.  Haemodynamic profile of an inhibitor of phosphodiesterase III, adibendan (BM 14.478): comparison with nitroprusside and dobutamine in conscious dogs.

Authors:  A Dorszewski; B Müller-Beckmann; L Kling; G Sponer
Journal:  Br J Pharmacol       Date:  1990-11       Impact factor: 8.739

Review 2.  Current status of phosphodiesterase inhibitors in the treatment of congestive heart failure.

Authors:  T A Fischer; R Erbel; N Treese
Journal:  Drugs       Date:  1992-12       Impact factor: 9.546

Review 3.  Intravenous vasodilator therapy in congestive heart failure.

Authors:  Kourosh Moazemi; Jatinder S Chana; Anna Marie Willard; Abraham G Kocheril
Journal:  Drugs Aging       Date:  2003       Impact factor: 3.923

4.  Comparative study of cardiovascular profiles of milrinone and amrinone by use of isolated, blood-perfused dog heart preparations.

Authors:  Y Sato; Y Wada; N Taira
Journal:  Heart Vessels       Date:  1986       Impact factor: 2.037
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.